Bank of America cut shares of Inovio Pharmaceuticals (NASDAQ:INO – Get Rating) from a neutral rating to an underperform rating in a research report sent to investors on Tuesday, Marketbeat Ratings reports. The brokerage currently has $2.00 price objective on the biopharmaceutical company’s stock. INO has been the topic of several other research reports. Royal […]
Equities analysts forecast that Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Get Rating) will announce sales of $430,000.00 for the current fiscal quarter, according to Zacks Investment Research. Three analysts have issued estimates for Inovio Pharmaceuticals’ earnings, with the highest sales estimate coming in at $850,000.00 and the lowest estimate coming in at $180,000.00. Inovio Pharmaceuticals reported […]
Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Get Rating) – Investment analysts at Cantor Fitzgerald issued their FY2023 earnings per share (EPS) estimates for Inovio Pharmaceuticals in a research note issued on Monday, June 6th. Cantor Fitzgerald analyst C. Duncan forecasts that the biopharmaceutical company will post earnings per share of ($1.50) for the year. Other equities […]
Several analysts have recently updated their ratings and price targets for Inovio Pharmaceuticals (NASDAQ: INO): 5/23/2022 – Inovio Pharmaceuticals was upgraded by analysts at StockNews.com to a “sell” rating. 5/11/2022 – Inovio Pharmaceuticals was downgraded by analysts at Oppenheimer Holdings Inc. from an “outperform” rating to a “market perform” rating. 5/11/2022 – Inovio Pharmaceuticals had […]
Equities analysts expect that Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Get Rating) will report sales of $430,000.00 for the current fiscal quarter, Zacks Investment Research reports. Three analysts have provided estimates for Inovio Pharmaceuticals’ earnings, with the lowest sales estimate coming in at $180,000.00 and the highest estimate coming in at $850,000.00. Inovio Pharmaceuticals reported sales […]